INFU on NYSE

InfuSystem Holdings, Inc

American surgical and medical instruments and apparatus company. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with Neuronetics, Inc., Xtant Medical (United States) or Heartflow, Inc., or pick any stock.

  • TickerINFU on NYSE2
  • IndustrySurgical & Medical Instruments & Apparatus2
  • HeadquartersRochester Hills, United States2
  • Incorporated inDE3
  • Business address3851 West Hamlin Road, Rochester Hills, Mi 483093
  • Filer categoryAccelerated filer, Smaller reporting company3
  • Legal formCorporation2
  • LEI549300F58N8PHJ4QUI592
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O REGISTERED AGENT SOLUTIONS, INC., 19904 Dover, United States2
  • Registered withDivision of Corporations, Department of State, 40118412

InfuSystem Holdings, Inc. ("we," "us," "our" or the "Company") is a Delaware corporation. Formed in 2005, the Company operates through its subsidiary InfuSystem, Inc., a Delaware corporation ("InfuSystem" or "ISI").4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

56.0%Gross margin5
8.3%Operating margin5
4.6%Net margin5
6.4%Revenue growth, 20255
11.6%Return on equity5
0.34×Debt to equity5
$23.8MFree cash flow5

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Patient Services And Device Solutions brought in 44% of the revenue InfuSystem Holdings, Inc broke down this way in fiscal 2025.

  1. Patient Services And Device Solutions$113.1M544%up 6% from 2024
  2. Patient Services$78.2M531%up 7% from 2024
  3. Device Solutions$64.1M525%up 4% from 2024
Business segments by year
Business segments20242025
Patient Services And Device Solutions$106.3M$113.1M
Patient Services$72.8M$78.2M
Device Solutions$61.7M$64.1M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue44¢$63.1M
  • Other costs49¢$69.7M
  • Income tax3¢$4.0M
  • Profit5¢$6.6M

Out of $143.4M in revenue.5

Where each dollar of operating cash went, fiscal 2025

  • Capital spending2¢$560.0K
  • Share buybacks40¢$9.9M
  • Kept or used elsewhere57¢$14.0M

Out of $24.4M of cash from operations.5

Financial statements

Revenue67895$143.4M in 2025+77% since 2019
0$50.0M$100.0M$150.0M2019: $81.1M$81.1M20192020: $97.4M$97.4M2020+20%2021: $102.4M$102.4M2021+5%2022: $109.9M$109.9M2022+7%2023: $125.8M$125.8M2023+14%2024: $134.9M$134.9M2024+7%2025: $143.4M$143.4M2025+6%
Gross profit67895$80.3M in 2025+71% since 2019
0$25.0M$50.0M$75.0M$100.0M2019: $46.9M$46.9M20192020: $58.8M$58.8M2020+25%2021: $58.5M$58.5M2021−0%2022: $60.6M$60.6M2022+3%2023: $63.1M$63.1M2023+4%2024: $70.4M$70.4M2024+12%2025: $80.3M$80.3M2025+14%
Operating income67895$11.9M in 2025+238% since 2019
0$5.0M$10.0M$15.0M2019: $3.5M$3.5M20192020: $8.8M$8.8M2020+150%2021: $2.8M$2.8M2021−68%2022: $1.7M$1.7M2022−41%2023: $4.1M$4.1M2023+147%2024: $6.9M$6.9M2024+69%2025: $11.9M$11.9M2025+73%
Net income67895$6.6M in 2025+387% since 2019
0$5.0M$10.0M$15.0M$20.0M2019: $1.4M$1.4M20192020: $17.3M$17.3M2020+1173%2021: $1.4M$1.4M2021−92%2022: $18.0K$18.0K2022−99%2023: $872.0K$872.0K2023+4744%2024: $2.3M$2.3M2024+169%2025: $6.6M$6.6M2025+183%

Every line of the income statement as filed: the last 2 fiscal years, latest first.5

Period ending2025-12-312024-12-31
Net revenues$143.4M$134.9M
Cost of revenues$63.1M$64.5M
Gross profit$80.3M$70.4M
Amortization of intangibles$920.0K$991.0K
Selling and marketing$10.5M$11.3M
General and administrative$57.0M$51.2M
Total selling, general and administrative$68.4M$63.5M
Operating income$11.9M$6.9M
Interest expense-$1.3M-$1.8M
Other income (expense)$2.0K-$55.0K
Income (Loss) before income taxes$10.6M$5.1M
Provision for income taxes-$4.0M-$2.7M
Basic (in dollars per share)$0.32$0.11
Diluted (in dollars per share)$0.31$0.11
Basic (in shares)20.7M shares21.3M shares
Diluted (in shares)21.1M shares21.7M shares
Net income$6.6M$2.3M
Unrealized gain (loss) on hedges-$733.0K$40.0K
(Provision for) benefit from income tax on unrealized hedge gain (loss)$179.0K-$9.0K
Other comprehensive income (loss)-$554.0K$31.0K
Net comprehensive income$6.1M$2.4M

Compare InfuSystem Holdings, Inc with another company

Leadership

Who has led InfuSystem Holdings, Inc, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (41)

Former names

  • HAPC, Inc.Apr 26, 2006 to Oct 30, 20073
  • Healthcare Acquisition Partners Corp.Oct 14, 2005 to Apr 25, 20063

Timeline

  1. Sep 25, 2025New chief executive Carrie Lachance becomes CEO13
  2. Dec 12, 2017New chief executive Richard Dilorio becomes CEO14
  3. Apr 1, 2013New chief executive Eric K. Steen becomes CEO15
  4. Apr 26, 2012New chief executive Dilip Singh becomes CEO16
  5. Dec 7, 2010New chief executive Sean McDevitt becomes CEO17
  6. Nov 21, 2007New chief executive Steven Watkins becomes CEO18
  7. Aug 15, 2005Founded InfuSystem Holdings, Inc is founded2

Filings

295 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 102 major events, 137 insider forms, 20 large holders, 16 other. The latest 20:

  1. Oct 13, 20264 EDGAR
  2. Sep 17, 20268-K EDGAR
  3. Sep 11, 20264 EDGAR
  4. Aug 4, 202610-Q EDGAR
  5. Aug 4, 20268-K EDGAR
  6. Aug 4, 20268-K EDGAR
  7. Jul 28, 2026SCHEDULE 13G EDGAR
  8. Jul 28, 20268-K EDGAR
  9. May 19, 20264 EDGAR
  10. May 19, 20264 EDGAR
  11. May 19, 20264 EDGAR
  12. May 19, 20264 EDGAR
  13. May 18, 20268-K EDGAR
  14. May 18, 2026S-8 EDGAR
  15. May 14, 20264 EDGAR
  16. May 14, 20264 EDGAR
  17. May 14, 20264 EDGAR
  18. May 14, 20264 EDGAR
  19. May 14, 20264 EDGAR
  20. May 14, 20264 EDGAR

The 295 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

68 open-market trades by officers, directors and large owners since October 2021: 21 buys and 47 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
May 11, 2026Lachance CarriePresident and CEOBuy1,000$8.46$8.5KForm 4
May 8, 2026GENDRON PAUL ANDREWDirectorBuy5,000$8.88$44.4KForm 4
May 8, 2026Lachance CarriePresident and CEOBuy2,000$8.83$17.7KForm 4
May 8, 2026Steele Barry GExecutive VP and CFOBuy7,000$8.71$61.0KForm 4
Mar 2, 2026Steele Barry GExecutive VP and CFOBuy2,064$9.16$18.9KForm 4
Aug 22, 2025Shuda ScottDirectorSale5,752$9.67$55.6KForm 4
May 28, 2025Eichenbaum Kenneth D.DirectorBuy2,000$5.18$10.4KForm 4
May 19, 2025Hundzinski Ronald TDirectorBuy5,000$6.09$30.4KForm 4
May 16, 2025Lachance CarriePresident and CEOBuy1,967$6.10$12.0KForm 4
May 15, 2025Lachance CarriePresident and CEOBuy1,165$6.01$7.0KForm 4
May 14, 2025Steele Barry GExecutive VP and CFOBuy3,000$5.76$17.3KForm 4
Nov 27, 2024Dilorio RichardChief Executive OfficerSale5,398$8.87$47.9KForm 4
Nov 26, 2024Dilorio RichardChief Executive OfficerSale14,602$8.91$130.1KForm 4
Nov 25, 2024Dilorio RichardChief Executive OfficerSale20,000$9.32$186.4KForm 4
Sep 23, 2024Eichenbaum Kenneth D.DirectorBuy4,000$5.89$23.6KForm 4
May 23, 2024BOYD RALPH F JRDirectorBuy4,000$7.13$28.5KForm 4
May 22, 2024HUSS BEVERLY ADirectorBuy4,300$6.86$29.5KForm 4
May 21, 2024Chupa AddamExecutive VP and CIOBuy1,000$6.67$6.7KForm 4
May 20, 2024Steele Barry GExecutive VP and CFOBuy3,000$6.47$19.4KForm 4
May 20, 2024Funke JerodEVP-Chief HR OfficerBuy1,000$6.39$6.4KForm 4

All 68 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.1,585,415$15.3M0.0%+968,829
Minerva Advisors LLC1,348,617$13.0M8.2%+144,512
First Eagle Investment Management, LLC1,240,000$12.0M0.0%+518,629
Punch & Associates Investment Management, Inc.834,750$8.1M0.4%−3,175
Vanguard Capital Management LLC790,775$7.6M0.0%−69,488
Heartland Advisors Inc700,000$6.8M0.3%+190,000
American Century Companies Inc675,028$6.5M0.0%+202,007
Dimensional Fund Advisors LP599,289$5.8M0.0%+5,001
Renaissance Technologies LLC543,009$5.2M0.0%−23,800
Geode Capital Management, LLC496,059$4.8M0.0%+277,614
Diamond Hill Capital Management, LLC (Investment Advisor)489,017$4.7M0.0%New
Meros Investment Management, LP468,934$4.5M1.4%−474
Hillsdale Investment Management Inc.424,473$4.1M0.1%−27,900
Arrowstreet Capital, Limited Partnership368,712$3.6M0.0%No change
White Pine Capital LLC225,634$2.2M0.5%−20,393
State Street Corp212,571$2.1M0.0%+114,500
Panagora Asset Management Inc194,922$1.9M0.0%+112,134
Teton Advisors, LLC185,000$1.8M1.0%No change
Expect Equity LLC184,819$1.8M1.1%+103,873
North Star Investment Management Corp.182,000$1.8M0.1%No change
Citadel Advisors LLC180,650$1.7M0.0%+10,696
Northern Trust Corp153,506$1.5M0.0%+96,695
Two Sigma Investments, LP148,347$1.4M0.0%−37,064
Gabelli Funds LLC145,085$1.4M0.0%−3,400
Vanguard Fiduciary Trust Co141,134$1.4M0.0%+19,146

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74